Adjunctive intravenous magnesium to reduce toxicity and enhance efficacy of class III antiarrhythmic agents.
Henyan
Nickole
N
Hartford Hospital, USA.
White
C Michael
CM
D000368:Aged; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000145:classification / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy*; D001282:Atrial Flutter / Q000188:drug therapy*; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008278:Magnesium Sulfate / Q000627:therapeutic use*; D008297:Male; D023421:Models, Animal; D011446:Prospective Studies; D012189:Retrospective Studies; D013449:Sulfonamides / Q000145:classification / Q000627:therapeutic use*
D000889:Anti-Arrhythmia Agents; D013449:Sulfonamides; C067192:ibutilide; D008278:Magnesium Sulfate